Oracle Fusion Cloud ERP Boosts Apollo Health & Lifestyle's Financial Health

India Pharma Outlook Team | Tuesday, 27 February 2024

 Diabetes Management Clinics, increase productivity, India Pharma Outlook

Photo:Representative Image

Apollo Health and Lifestyle Limited, one of India’s largest retail healthcare companies, has selected Oracle Fusion Cloud Enterprise Resource Planning (ERP) to optimize its financial operations and increase productivity. 

With Oracle Cloud ERP, Apollo Health and Lifestyle will be able to eliminate manual processes and embrace continuous innovation to improve speed and accuracy in reporting, align financial and operational planning, and gain insights to drive better decisions.

Apollo Health and Lifestyle, a subsidiary of Apollo Hospitals Enterprise Limited (AHEL), runs the largest chain of standardized primary healthcare Models – Multispecialty Clinics under the brand name “Apollo Clinic” in India and the Middle East, Diabetes Management Clinics under Apollo Sugar, Dental Clinics under Apollo Dental and Diagnostic Centres under Apollo Diagnostics.

The Company also operates Specialty formats under Apollo Cradle (a Centre for Women and Children), Apollo Fertility (a center for providing infertility treatment), Apollo Spectra Hospitals (a hospital for minimally invasive surgeries) and Apollo Dialysis (A Chain of Dialysis Centres).

Apollo Health and Lifestyle’s finance and operations data was dispersed across multiple siloed on-premises applications, making it challenging to get accurate real-time information. To streamline its finance operations, improve automation, accelerate reporting, and expand insights, Apollo Health and Lifestyle selected Oracle Cloud ERP.

Oracle Cloud ERP will enable Apollo Health and Lifestyle to increase productivity, reduce costs, and improve controls. In addition, Oracle Fusion Cloud Enterprise Performance Management (EPM), part of Oracle Cloud ERP, will help improve the speed and accuracy of financial reporting, reduce the time to close the books, and enable senior leaders to make better decisions.

© 2024 India Pharma Outlook. All Rights Reserved.